{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T04:10:06Z","timestamp":1778299806025,"version":"3.51.4"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ital J Pediatr"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13052-018-0444-6","type":"journal-article","created":{"date-parts":[[2018,1,16]],"date-time":"2018-01-16T07:58:12Z","timestamp":1516089492000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Children with premature pubarche: is an alterated neonatal 17-Ohp screening test a predictive factor?"],"prefix":"10.1186","volume":"44","author":[{"given":"Paolo","family":"Cavarzere","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margherita","family":"Mauro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monica","family":"Vincenzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvana","family":"Lauriola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Teofoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rossella","family":"Gaudino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diego Alberto","family":"Ramaroli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rocco","family":"Micciolo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Camilot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franco","family":"Antoniazzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,1,16]]},"reference":[{"key":"444_CR1","doi-asserted-by":"publisher","first-page":"4048","DOI":"10.1210\/jc.2002-020611","volume":"87","author":"Joint ESPE\/LWPES CAH working group","year":"2002","unstructured":"Joint ESPE\/LWPES CAH working group. Consensus statement on 21-hydroxylase deficiency from the Lawson Wilkins pediatric Endocrine Society and the European Society for Paediatric Endocrinology. J Clin Endocrinol Metab. 2002;87:4048\u201353.","journal-title":"J Clin Endocrinol Metab"},{"key":"444_CR2","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/S0889-8529(08)70017-3","volume":"30","author":"BL Therrell","year":"2001","unstructured":"Therrell BL. Newborn screening for congenital adrenal hyperplasia. Endocrinol Metab Clin N Am. 2001;30:15\u201330.","journal-title":"Endocrinol Metab Clin N Am"},{"key":"444_CR3","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1542\/peds.106.6.1511","volume":"106","author":"American Academy of Pediatrics, section on Endocrinology and Committee on Genetics","year":"2000","unstructured":"American Academy of Pediatrics, section on Endocrinology and Committee on Genetics. Techical report: congenital adrenal hyperplasia. Pediatrics. 2000;106:1511\u20138.","journal-title":"Pediatrics"},{"key":"444_CR4","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1001\/jamapediatrics.2013.5321","volume":"168","author":"S Gidl\u00f6f","year":"2014","unstructured":"Gidl\u00f6f S, Wedell A, Guthenberg C, von D\u00f6beln U, Nordenstr\u00f6m A. Nationwide neonatal screening for congenital adrenal hyperplasiain sweden: a 26-year longitudinal prospective population-based study. JAMA Pediatr. 2014;168:567\u201374.","journal-title":"JAMA Pediatr"},{"key":"444_CR5","first-page":"284","volume":"67","author":"SD Grosse","year":"2007","unstructured":"Grosse SD, Van Vliet G. How many deaths can be prevented by newborn screening for congenital adrenal hyperplasia? Horm Res. 2007;67:284\u201391.","journal-title":"Horm Res"},{"key":"444_CR6","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1001\/archpediatrics.2011.774","volume":"166","author":"B Coulm","year":"2012","unstructured":"Coulm B, Coste J, Tardy V, Ecosse E, Roussey M, Morel Y, Carel JC, DHCSF Study Group. Efficiency of neonatal screening for congenital adrenal hyperplasia due to 21-hydroxylase deficiency in children born in mainland France between 1996 and 2003. Arch Pediatr Adolesc Med. 2012;166:113\u201320.","journal-title":"Arch Pediatr Adolesc Med"},{"key":"444_CR7","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1530\/EJE-09-0145","volume":"161","author":"P Cavarzere","year":"2009","unstructured":"Cavarzere P, Samara-Boustani D, Flechtner I, Dechaux M, Elie C, Tardy V, Morel Y, Polak M. Transient hyper-17-hydroxyprogesteronemia: a clinical subgroup of patients diagnosed at neonatal screening for congenital adrenal hyperplasia. Eur J Endocrinol. 2009;161:285\u201392.","journal-title":"Eur J Endocrinol"},{"key":"444_CR8","first-page":"274","volume":"53","author":"EN G\u00f6n\u00e7","year":"2011","unstructured":"G\u00f6n\u00e7 EN, Oz\u00f6n ZA, Alika\u015fifo\u011flu A, Engiz O, Bulum B, Kandemir N. Is basal serum 17-OH progesterone a reliable parameter to predict nonclassical congenital adrenal hyperplasia in premature adrenarche? Turk J Pediatr. 2011;53:274\u201380.","journal-title":"Turk J Pediatr"},{"key":"444_CR9","doi-asserted-by":"publisher","first-page":"2835","DOI":"10.1210\/jc.2009-0314","volume":"94","author":"CML ArmengaudJB","year":"2009","unstructured":"ArmengaudJB CML, Trivin C, Tardy V, Br\u00e9art G, Brauner R, Chalumeau M. Precocious pubarche: distinguishing late-onset congenital adrenal hyperplasia from premature adrenarche. J Clin Endocrinol Metab. 2009;94:2835\u201340.","journal-title":"J Clin Endocrinol Metab"},{"key":"444_CR10","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1530\/EJE-11-0119","volume":"165","author":"L Ghizzoni","year":"2011","unstructured":"Ghizzoni L, Cappa M, Vottero A, Ubertini G, Carta D, Di Iorgi N, Gasco V, Marchesi M, Raggi V, Ibba A, Napoli F, Massimi A, Maghnie M, Loche S, Porzio O. Relationship of CYP21A2 genotype and serum 17-hydroxyprogesterone and cortisol levels in a large cohort of Italian children with premature pubarche. Eur J Endocrinol. 2011;165:307\u201314.","journal-title":"Eur J Endocrinol"},{"key":"444_CR11","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1111\/cen.12543","volume":"82","author":"S Livadas","year":"2015","unstructured":"Livadas S, Dracopoulou M, Dastamani A, Sertedaki A, Maniati-Christidi M, Magiakou AM, Kanaka-Gantenbein C, Chrousos GP, Dacou-Voutetakis C. The spectrum of clinical, hormonal and molecular findings in 280 individuals with nonclassical congenital adrenal hyperplasia caused by mutations of the CYP21A2 gene. Clin Endocrinol. 2015;82:543\u20139.","journal-title":"Clin Endocrinol"},{"key":"444_CR12","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/j.metabol.2008.01.010","volume":"57","author":"RP Mathew","year":"2008","unstructured":"Mathew RP, Byrne DW, Linton MF, Vaughan DE, Fazio S, Russell WE. Evidence of metabolic syndrome in lean children with premature pubarche at diagnosis. Metabolism. 2008;57:733\u201340.","journal-title":"Metabolism"},{"key":"444_CR13","doi-asserted-by":"publisher","first-page":"4282","DOI":"10.1210\/jc.2006-2412","volume":"92","author":"P Utriainen","year":"2007","unstructured":"Utriainen P, J\u00e4\u00e4skel\u00e4inen J, Romppanen J, Voutilainen R. Childhood metabolic syndrome and its components in premature adrenarche. J Clin Endocrinol Metab. 2007;92:4282\u20135.","journal-title":"J Clin Endocrinol Metab"},{"key":"444_CR14","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1136\/adc.51.3.170","volume":"51","author":"JM Tanner","year":"1976","unstructured":"Tanner JM, Whitehouse RH. Clinical longitudinal standards for height, weight, height velocity, weight velocity, and stages of puberty. Arch Dis Child. 1976;51:170\u20139.","journal-title":"Arch Dis Child"},{"key":"444_CR15","volume-title":"Radiographic atlas of skeletal development of the hand and wrist","author":"WW Greulich","year":"1959","unstructured":"Greulich WW, Pyle SI. Radiographic atlas of skeletal development of the hand and wrist. 2nd ed. Stanford: Stanford University Press; 1959.","edition":"2"},{"key":"444_CR16","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1210\/jcem-57-2-320","volume":"57","author":"MI New","year":"1983","unstructured":"New MI, Lorenzen F, Lerner AJ, Kohn B, Oberfield SE, Pollack MS, Dupont B, Stoner E, Levy DJ, Panq S, Levine LS. Genotyping steroid 21-hydroxylase deficiency: hormonal reference data. J Clin Endocrinol Met. 1983;57:320\u20136.","journal-title":"J Clin Endocrinol Met"},{"key":"444_CR17","first-page":"671","volume":"21","author":"L Ib\u00e1\u00f1ez","year":"2000","unstructured":"Ib\u00e1\u00f1ez L, Dimartino-Nardi J, Potau N, Saenger P. Premature adrenarche--normal variant or forerunner of adult disease? Endocr Rev. 2000;21:671\u201396.","journal-title":"Endocr Rev"},{"key":"444_CR18","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1136\/archdischild-2011-300011","volume":"97","author":"RM Williams","year":"2012","unstructured":"Williams RM, Ward CE, Hughes IA. Premature adrenarche. Arch Dis Child. 2012;97:250\u20134.","journal-title":"Arch Dis Child"},{"key":"444_CR19","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1159\/000369458","volume":"83","author":"P Utriainen","year":"2015","unstructured":"Utriainen P, Laakso S, Liimatta J, J\u00e4\u00e4skel\u00e4inen J, Voutilainen R. Premature adrenarche--a common condition with variable presentation. Horm Res Paediatr. 2015;83:221\u201331.","journal-title":"Horm Res Paediatr"},{"key":"444_CR20","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1515\/jpem-2015-0252","volume":"29","author":"BA Ghanny","year":"2016","unstructured":"Ghanny BA, Malhotra S, Kumta S, Kazachkova I, Homel P, Jacobson-Dickman E, Motaghedi R. Should children with isolated premature adrenarche be routinely evaluated for non-classical congenital adrenal hyperplasia? J Pediatr Endocrinol Metab. 2016;29:351\u20136.","journal-title":"J Pediatr Endocrinol Metab"},{"key":"444_CR21","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1159\/000184592","volume":"44","author":"L Ib\u00e1\u00f1ez","year":"1995","unstructured":"Ib\u00e1\u00f1ez L, Bonnin MR, Zampolli M, Prat N, Alia PJ, Navarro MA. Usefulness of an ACTH test in the diagnosis of nonclassical 21-hydroxylase deficiency among children presenting with premature pubarche. Horm Res. 1995;44:51\u20136.","journal-title":"Horm Res"},{"key":"444_CR22","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1210\/jcem-42-1-117","volume":"42","author":"S Korth-Schutz","year":"1976","unstructured":"Korth-Schutz S, Levine LS, New MI. Serum androgens in normal prepubertal and pubertal children and in children with precocious puberty. J Clin Endocrinol Metab. 1976;42:117\u201324.","journal-title":"J Clin Endocrinol Metab"},{"key":"444_CR23","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/BF03350247","volume":"14","author":"MV Leite","year":"1991","unstructured":"Leite MV, Mendon\u00e7a BB, Arnhold IJ, Estefan V, Nunes C, Nicolau W, Bloise W. Identification of nonclassical 21-hydroxylase deficiency in girls with precocious pubarche. J Endocrinol Investig. 1991;14:11\u20135.","journal-title":"J Endocrinol Investig"},{"key":"444_CR24","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.jsbmb.2014.06.004","volume":"145","author":"R Voutilainen","year":"2015","unstructured":"Voutilainen R, J\u00e4\u00e4skel\u00e4inen J. Premature adrenarche: etiology, clinical findings, and consequences. J Steroid Biochem Mol Biol. 2015;145:226\u201336.","journal-title":"J Steroid Biochem Mol Biol"},{"key":"444_CR25","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1530\/acta.0.112S284","volume":"279","author":"D Knorr","year":"1986","unstructured":"Knorr D, Bidlingmaier F, H\u00f6ller W, Kuhnle U, Meiler B, Nachmann A. Is heterozygosity for the steroid 21-hydroxylase deficiency responsible for hirsutism, premature pubarche, early puberty, and precocious puberty in children? Acta Endocrinol Suppl (Copenh). 1986;279:284\u20139.","journal-title":"Acta Endocrinol Suppl (Copenh)"},{"key":"444_CR26","first-page":"650","volume":"37","author":"PW Speiser","year":"1985","unstructured":"Speiser PW, Dupont B, Rubinstein P, Piazza A, Kastelan A, New MI. High frequency of nonclassical steroid 21-hydroxylase deficiency. Am J Hum Genet. 1985;37:650\u201367.","journal-title":"Am J Hum Genet"},{"key":"444_CR27","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1007\/s40618-014-0223-1","volume":"38","author":"N Skordis","year":"2015","unstructured":"Skordis N, Shammas C, Phedonos AA, Kyriakou A, Toumba M, Neocleous V, Phylactou LA. Genetic defects of the CYP21A2 gene in girls with premature adrenarche. J Endocrinol Investig. 2015;38:535\u20139.","journal-title":"J Endocrinol Investig"},{"key":"444_CR28","first-page":"40","volume":"210","author":"V Neocleous","year":"2012","unstructured":"Neocleous V, Shammas C, Phedonos AP, Karaoli E, Kyriakou A, Toumba M, Phylactou LA, Skordis N. Genetic defects in the cyp21a2 gene in heterozygous girls with premature adrenarche and adolescent females with hyperandrogenemia. Georgian Med News. 2012;210:40\u20137.","journal-title":"Georgian Med News"},{"key":"444_CR29","first-page":"479","volume":"82","author":"ES Knochenhauer","year":"1997","unstructured":"Knochenhauer ES, Cortet-Rudelli C, Cunnigham RD, Conway-Myers BA, Dewailly D, Azziz R. Carriers of 21-hydroxylase deficiency are not at increased risk for hyperandrogenism. J Clin Endocrinol Metab. 1997;82:479\u201385.","journal-title":"J Clin Endocrinol Metab"},{"key":"444_CR30","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S0015-0282(99)00317-9","volume":"72","author":"HF Escobar-Morreale","year":"1999","unstructured":"Escobar-Morreale HF, San Mill\u00e1n JL, Smith RR, Sancho J, Witchel SF. The presence of the 21-hydroxylase deficiency carrier status in hirsute women: phenotype-genotype correlations. Fertil Steril. 1999;72:629\u201338.","journal-title":"Fertil Steril"},{"key":"444_CR31","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1111\/j.1365-2265.2006.02521.x","volume":"64","author":"O Admoni","year":"2006","unstructured":"Admoni O, Israel S, Lavi I, Gur M, Tenenbaum-Rakover Y. Hyperandrogenism in carriers of CYP21 mutations: the role of genotype. Clin Endocrinol. 2006;64:645\u201351.","journal-title":"Clin Endocrinol"},{"key":"444_CR32","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1006\/bmme.1997.2632","volume":"62","author":"SF Witchel","year":"1997","unstructured":"Witchel SF, Lee PA, Suda-Hartman M, Hoffman EP. Hyperandrogenism and manifesting heterozygotes for 21-hydroxylase deficiency. Biochem Mol Med. 1997;62:151\u20138.","journal-title":"Biochem Mol Med"},{"key":"444_CR33","first-page":"201","volume":"55","author":"Working Group on Neonatal Screening of the European Society for Paediatric Endocrinology","year":"2001","unstructured":"Working Group on Neonatal Screening of the European Society for Paediatric Endocrinology. Procedure for neonatal screening for congenital adrenal hyperplasia due to 21-hydroxilase deficiency. Horm Res. 2001;55:201\u20135.","journal-title":"Horm Res"},{"key":"444_CR34","doi-asserted-by":"publisher","first-page":"2125","DOI":"10.1016\/S0140-6736(05)66736-0","volume":"365","author":"DP Merke","year":"2005","unstructured":"Merke DP, Bornstein SR. Congenital adrenal hyperplasia. Lancet. 2005;365:2125\u201336.","journal-title":"Lancet"},{"key":"444_CR35","first-page":"245","volume":"21","author":"PC White","year":"2000","unstructured":"White PC, Speiser PW. Congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Endocr Rev. 2000;21:245\u201391.","journal-title":"Endocr Rev"},{"key":"444_CR36","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/0925-6164(94)90003-5","volume":"3","author":"T Torresani","year":"1994","unstructured":"Torresani T, Gr\u00fcters A, Acherz R. Improving the efficacy of newborn screening for congenital adrenal hyperplasia by adjusting the cut-off level of 17-\u03b1-hydroxyprogesterone to gestational age. Screening. 1994;3:77\u201384.","journal-title":"Screening"},{"key":"444_CR37","first-page":"206","volume":"55","author":"JW Honour","year":"2001","unstructured":"Honour JW, Torresani T. Evaluation of neonatal screening for congenital adrenal hyperplasia. Horm Res. 2001;55:206\u201311.","journal-title":"Horm Res"},{"key":"444_CR38","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1177\/000456328602300510","volume":"23","author":"J Berry","year":"1986","unstructured":"Berry J, Betts P, Wood PJ. The interpretation of blood spot 17\u03b1-hydroxyprogesterone levels in term and pre-term neonates. Ann Clin Biochem. 1986;23:546\u201351.","journal-title":"Ann Clin Biochem"},{"key":"444_CR39","doi-asserted-by":"publisher","first-page":"3904","DOI":"10.1210\/jc.2004-2136","volume":"90","author":"HJ Van Der Kamp","year":"2005","unstructured":"Van Der Kamp HJ, Oudshoorn CGM, Elvers BH, Van Baarle M, Otten BJ, Wit JM, Verkerk PH. Cut-off level of 17-\u03b1-hydroxyprogesterone in neonatal screening for congenital adrenal hyperplasia should be based on gestational age rather than on birth weight. J Clin Endocrinol Metab. 2005;90:3904\u20137.","journal-title":"J Clin Endocrinol Metab"},{"key":"444_CR40","doi-asserted-by":"publisher","DOI":"10.1542\/peds.108.4.e68","volume":"108","author":"A Nordenstr\u00f6m","year":"2001","unstructured":"Nordenstr\u00f6m A, Wedell A, Hagenfeldt L, Marcus C, Larsson A. Neonatal screening for congenital adrenal hyperplasia: 17-hydroxyprogesterone levels and CYP21 genotypes in preterm infants. Pediatrics. 2001;108:e68.","journal-title":"Pediatrics"},{"key":"444_CR41","first-page":"271","volume":"55","author":"L Gru\u00f1eiro-Papendieck","year":"2001","unstructured":"Gru\u00f1eiro-Papendieck L, Prieto L, Chiesa A, Bengolea S, Bossi G, Bergad\u00e1 C. Neonatal screening program for congenital adrenal hyperplasia: adjustments to the recall protocol. Horm Res. 2001;55:271\u20137.","journal-title":"Horm Res"},{"key":"444_CR42","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/S0022-3476(97)70321-4","volume":"130","author":"DB Allen","year":"1997","unstructured":"Allen DB, Hoffman GL, Fitzpatrick P, Laessing R, Maby S, Slyper A. Improved precision of newborn screening for congenital adrenal hyperplasia using weight-adjusted criteria for 17-hydroxyprogesterone levels. J Pediatr. 1997;130:128\u201333.","journal-title":"J Pediatr"},{"key":"444_CR43","doi-asserted-by":"publisher","first-page":"5790","DOI":"10.1210\/jc.2002-021732","volume":"88","author":"B Olgem\u00f6ller","year":"2003","unstructured":"Olgem\u00f6ller B, Roscher AA, Liebl B, Fingerhut R. Screening for congenital adrenal hyperplasia: adjustment of 17-hydroxyprogesterone cut-off values to both age and birth weight markedly improves the predictive value. J Clin Endocrinol Metab. 2003;88:5790\u20134.","journal-title":"J Clin Endocrinol Metab"},{"key":"444_CR44","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1111\/cen.13292","volume":"86","author":"GY Hayashi","year":"2017","unstructured":"Hayashi GY, Carvalho DF, de Miranda MC, Faure C, Vallejos C, Brito VN, Rodrigues AS, Madureira G, Mendonca BB, Bachega TA. Neonatal 17-hydroxyprogesterone levels adjusted according to age at sample collection and birthweight improve the efficacy of congenital adrenal hyperplasia newborn screening. Clin Endocrinol. 2017;86:480\u20137.","journal-title":"Clin Endocrinol"},{"key":"444_CR45","first-page":"180","volume":"63","author":"P Cavarzere","year":"2005","unstructured":"Cavarzere P, Camilot M, Teofoli F, Tat\u00f2 L. Neonatal screening for congenital adreanl hyperplasia in North-eastern Italy: a report three years into the program. Horm Res. 2005;63:180\u20136.","journal-title":"Horm Res"},{"key":"444_CR46","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1210\/jcem-69-6-1133","volume":"69","author":"MM Lee","year":"1989","unstructured":"Lee MM, Rajagopalan L, Berg GJ, Moshang T Jr. Serum adrenal steroid concentrations in premature infants. J Clin Endocrinol Metab. 1989;69:1133\u20136.","journal-title":"J Clin Endocrinol Metab"},{"key":"444_CR47","first-page":"266","volume":"78","author":"RV Hingre","year":"1994","unstructured":"Hingre RV, Gross SJ, Hingre KS, Mayes DM, Richman RA. Adrenal steroidogenesis in very low birth weight preterm infants. J Clin Endocrinol Metab. 1994;78:266\u201370.","journal-title":"J Clin Endocrinol Metab"},{"key":"444_CR48","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1111\/j.1442-200X.1992.tb00938.x","volume":"34","author":"S Ohkubo","year":"1992","unstructured":"Ohkubo S, Shimozawa K, Matsumoto M, Kitagawa T. Analysis of blood spot 17-alpha-hydroxyprogesterone concentration in premature infants: proposal for cut-off limits in screening for congenital adrenal hyperplasia. Acta Paediatr Jpn. 1992;34:126\u201333.","journal-title":"Acta Paediatr Jpn"},{"key":"444_CR49","first-page":"1503","volume":"84","author":"AW Root","year":"1999","unstructured":"Root AW. Editorial: neonatal screening for 21-hydroxylase deficient congenital adrenal hyperplasia-the role of CYP21 analysis. J Clin Endocrinol Metab. 1999;84:1503\u20134.","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Italian Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13052-018-0444-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,15]],"date-time":"2019-01-15T19:37:27Z","timestamp":1547581047000},"score":1,"resource":{"primary":{"URL":"https:\/\/ijponline.biomedcentral.com\/articles\/10.1186\/s13052-018-0444-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,16]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["444"],"URL":"https:\/\/doi.org\/10.1186\/s13052-018-0444-6","relation":{},"ISSN":["1824-7288"],"issn-type":[{"value":"1824-7288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,16]]},"assertion":[{"value":"13 September 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was conducted in compliance with the terms of the Helsinki II Declaration. In Italy, this type of clinical study does not require Institutional Review Board\/Institutional Ethics Committee approval to publish the results. Written informed consent was obtained from the parents of each patient.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors have obtained consent to publish from the parents of all the patients.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that there are no competing interests that could be perceived as prejudicing the impartiality of the affirmation reported.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"10"}}